Get started
Author

Océane Hache

Observed names: O. Hache, Oceane Hache
OpenAlex ID: A5025798271
Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol
2022 · David Boulate, Marine Fidelle, et al. · BMJ Open · 10
PDF
Safety and efficacy of transcatheter correction of sinus venosus defect using 70–100 mm-long partially covered Optimus-CVS® XXL stents compared with surgery: The OPTIVENOSUS study design
2025 · Clément Batteux, Vlad Ciobotaru, et al. · Archives of cardiovascular diseases · 6
P62.01 PREVALUNG: Evaluation of Lung Cancer Prevalence in Patients With Smocking-associated Atherosclerotic Cardiovascular Diseases
2021 · D. Boulate, J. Issard, et al. · Journal of Thoracic Oncology · 1
PDF
First round of lung cancer screening among patients with atheromatous cardiovascular disease exposed to tobacco: a prospective cohort study
2026 · Elsa Armand, Clarisse Buton, et al. · Respiratory Medicine and Research
PDF
Glycometabolic, inflammatory and exocrine plasma proteins predict cancer in individuals with cardiovascular disease
2026 · Marine Fidelle, David Boulate, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
EP.04.29 Tobacco-Related Atheromatous Disease as Eligibility Criteria for Lung Cancer Screening: A Prospective Evaluation
2025 · E. Armand, C. Buton, et al. · Journal of Thoracic Oncology
P1.04.39 Markov Model Approach to Optimize Lung Cancer Screening and Early Detection in Patients With Smoking Associated Diseases
2025 · C. Buton, P. Pradère, et al. · Journal of Thoracic Oncology
P1.18-03 Patients with Smoking-Associated Atherosclerotic Cardiovascular Diseases: Does Prevalung Refines Eligibility for Screening?
2023 · D. Boulate, M. Fidelle, et al. · Journal of Thoracic Oncology
PDF
Works count: 8
Citation count: 17
H-index: 2
I10-index: 1
Year
Topic
Type